001

RESEARCH & DEVELOPMENT

At Future Pharma, our research is not focused on conventional, suboptimal supplements, nor on effective but harmful PEDs (Performance-Enhancing Drugs).

Instead, we develop a next-generation category of performance-enhancing biotech that combines the best of both approaches, without the limitations of either.

THE FIRST HUMAN CLINICALLY VALIDATED BIOPHARMA TO SAFELY AND PROFOUNDLY ENHANCE HUMAN PERFORMANCE AT THE UNDERLYING MOLECULAR LEVEL ///////////

UNIVERSITY OF OXFORD TRI-VITAMIN COMPLEX SLOWED BRAIN GREY MATTER ATROPHY BY 30% - 86%.

Brain Grey Matter Atrophy

HEADLINE DATA . //////////


Greater Exercise Capacity

80%

Das, Abhirup et al. Harvard Medical School.



Testosterone Elevation

30%

Wei Li, Texas Tech University



Muscle Growth

346%

Ebert, Scott M et al. University of IOWA



2.0KG

Muscle Gain

Isenmann, Eduard et al. German Sport University Cologne


002 

COMMITTED TO REAL SCIENCE,
NOT PSEUDOSCIENCE.

At our core, we stand against pseudoscience. For over 15 years, we have pioneered meaningful scientific discoveries in aging and performance by conducting rigorous preclinical research through to full human clinical trials.

Our commitment to the clinical validation of new biotechnology sets us apart from other dietary supplement companies that rely on marketing existing nutritional products with unsubstantiated claims.


11+

Patents

Proprietary Technology Unavailable elsewhere



11+

Human Clinical Trials

Completed and ongoing clinical trials involving over 1000 participants



15+

Years of Research

In Collaboration with Leading Institutions and Scientists.



500+

Pre Clinical Studies

Scientists have extensively explored the effectiveness of Futures Compounds


////////////DISCOVER OUR RESEARCH

Xaging decline balance strength cardio endurance
003

WE ARE HARNESSING THE BIOLOGY OF HUMAN AGING TO DEVELOP RADICAL NEW TECHNOLOGIES HUMAN ENHANCEMENT.

Traditionally, pharmaceuticals have exclusively targeted the treatment of dysfunction. However, if you are an adult, you are already in decline—the effects of aging, such as loss of muscle mass and slowed metabolism, have already begun.

At Future, our research doesn’t merely aim to enhance performance at the symptom level. Instead, we pioneer the new field of human enhancement by identifying and targeting the root causes of aging at the most effective molecular and cellular levels.

WELCOME TO THE FUTURE

////////////

WELCOME TO THE FUTURE ////////////

004

WHY TACKLE AGING
TO ENHANCE PERFORMANCE?

Because despite seemingly opposite goals, the two are inextricably connected. Medicine almost exclusively begins by saving people from falling below the norm, but the same tools and knowledge can be used to surpass the norm.

By understanding and reverse-engineering the mechanisms underlying the root causes of the body’s decline, we gain the knowledge to elevate its counterpart: performance elevation—not as a vague and disjointed goal, but with fundamental precision and efficacy.

AGING

>>>

AGING >>>

ENHANCEMENT

<<<

ENHANCEMENT <<<

DECLINE VS ENHACEMENT

005

Because we believe that recent scientific advancements in the field of aging research have resulted in new developments that have fundamentally redefined our ability to decode performance.

Landmark scientific discoveries in the past 20 years—from the decoding of the human genome to the identification of the sub-cellular causes of aging—have shifted science from the tacit acceptance of human performance as being an immovable static to one that is highly adaptable, redefining every aspect of our ability to elevate it.

WHY NOW?

THE SCIENTIFIC BREAKTHROUGHS TO BEAT AGING AND REDEFINE THE LIMITS OF HUMAN PERFORMANCE HAS ARRIVED ///////////

//‘Today we are learning the language in which God created life’’

Former US President Bill Clinton.

HUMAN GENOME PROJECT CRACKS THE GENETIC CODE OF LIFE AFTER 32 YEARS AND $3BILLION ///////////

006

THE WORLD’S FIRST STUDY PROVING THAT AGING CAN BE BIOLOGICALLY HACKED

Until recently, immortality was considered pure fantasy.

In what has now become one of the defining studies in anti-aging, research conducted at the University of California, San Francisco (UCSF) proved that the rate of aging can, in fact, be biologically manipulated. By upregulating the daf-2 gene in animals, researchers not only doubled their lifespan, but the animals also appeared younger and healthier.

Crucially, the daf-2 pathways are "evolutionarily conserved," meaning they are also present in—and can be targeted in—humans.


CHECK OUT  (UCSF) PAPER IN NATURE TITLED:

“ Mutant That Lives Twice As Long .”



 IMMORTALITY BREAKS NO LAW OF SCIENCE

It already exists in one species Turritopsis dohrnii - the ‘immortal Jellyfish’


007

FOR THE FIRST TIME IN HISTORY, WE POSESS THE BIOTECHNOLOGIES TO EXCEED ALL NORMAL HUMAN LIMITS. ///////////

HARNESSING EXPONENTIAL TECHNOLOGY TO DEVELOP EXTRAORDINARY BIOPHARMA. 

While human aspiration for anti-aging has always been high— holy grails to elixirs of life—it has not been matched by the technological capabilities required for its realization.

At Future, we operate at the convergence of radical technological and scientific breakthroughs that have revolutionized our ability to identify the genetic pathways that control our biology and target with a new generation of enhanced biomolecules.

THE R&D JOURNEY ///////////


1.GENETICS & GENOMICS

Decoding the genetic basis behind human performance and identifying master molecular targets.

DNA


2.BIO-
TECHNOLOGY

Engineering patented molecules at the atomic level to activate molecular targets with greater potency.

BioTech


3. NANO-
TECHNOLOGY

BioTech

Encapsulating bioactive compounds to protect from digestive degradation and deliver direct to target cells.



4. ARTIFICAL
INTELLIGENCE

Accelerating the rate of drug discovery by modeling complex biological systems and predicting compound efficacy.

BioTech

DISCOVER FUTURES TECH

008

IF YOU THINK THIS ALL SOUNDS IMPOSSIBLE—THE STUFF OF SCIENCE FICTION—
THEN THINK AGAIN

In the past few years, scientists have made major advances in delaying aging and enhancing performance in animals. They’ve increased lifespans by 45-65%, elevated endurance by 80%, and boosted muscle growth by 30%—all with a new generation of safe and legal biomolecules.

THE TIME TO REPLICATE THIS SUCCESS IN HUMANS IS NOW.

  • MOLECULE: MIB-626
    MOLECULAR TARGET - SIRT 1-7
    CELLULAR PROCESS: Mitochondrial Biogenesis
    CLINICAL DATA: 80% 
    STUDY: “Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging.” Cell vol. 173,1 (2018): 74-89.e20. doi:10.1016/j.cell.2018.02.008

    Animals showed between 56 and 80 percent greater exercise capacity, compared with untreated mice the study showed. The NMN-treated animals managed to run 430 meters, or about 1,400 feet, on average, compared with 240 meters, or 780 feet, on average, for their untreated peers

Natural Anabolic Beta Ursolic Acid
  • MOLECULE: URSOLIC ACID
    MOLECULAR TARGET: ATF4
    CELLULAR PROCESS: MUSCLE SYNTHESIS
    HEADLINE DATA: 30% MUSCLE GROWTH

    STUDY: Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy

    Ebert SM, Dyle MC, Bullard SA, Dierdorff JM, Murry DJ, Fox DK, Bongers KS, Lira VA, Meyerholz DK, Talley JJ, Adams CM. Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy. J Biol Chem. 2015 Oct 16;290(42):25497-511. doi: 10.1074/jbc.M115.681445. Epub 2015 Sep 3. PMID: 26338703; PMCID: PMC4646196.

Cow
  • MOLECULE: FOLLISTATIN ANALOGUE FST-DHBS
    MOLECULAR TARGET: MYOSTATIN
    CELLULAR PROCESS: MUSCLE DEGRADATION
    HEADLINE DATA: 19% MUSCLE GROWTH IN 7 DAYS

    STUDY:
    Lodberg A, van der Eerden BCJ, Boers-Sijmons B, Thomsen JS, Brüel A, van Leeuwen JPTM, Eijken M. A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice. FASEB J. 2019 May;33(5):6001-6010. doi: 10.1096/fj.201801969RR. Epub 2019 Feb 13. PMID: 30759349.

Hericium
  • MOLECULE: Hericerin
    MOLECULAR TARGET: BDNF
    CELLULAR PROCESS: NEUROGENISIS
    HEADLINE DATA: 60.6% NEURON GROWTH

    STUDY: Hericerin derivatives from Hericium erinaceus exert BDNF-like neurotrophic activity in central hippocampal neurons and enhance memory

    bioRxiv 2020.08.28.271676; doi: https://doi.org/10.1101/2020.08.28.271676

009

MICE ARE NOT HUMANS

ENHANCED HUMANS ARE NO LONGER SCIENCE FICTION

BREAKTHROUGH MOLECULES AND SCIENTIFIC DISCOVERIES

The dietary supplement industry exclusively relies on in-vitro or animal studies, which,
while providing valuable insights,
fail to test real-world human efficacy.

We are one of the first performance enhancement companies to conduct full human clinical validation of our nutraceuticals, working with world leading universities under the strictest pharmaceutical standards—the only route to developing truly effective products for human enhancement.

010

STUDIED IN THE LAB, CLINICALLY VALIDATED IN HUMANS

/////////// WORKING WITH THE WORLDS ELITE HUMAN ENHANCEMENT PROGRAMS.

  • U.S. Special Operations Command (SOCOM)—which develops and employs Special Operations Forces worldwide to advance U.S. policies and objectives—has “completed preclinical safety and dosing studies in anticipation of follow-on performance testing” of a first-in-class nicotinamide adenine dinucleotide, oxidized state (NAD+) enhancer, a small molecule drug being developed by Metro International Biotech (MetroBiotech).

    “In preclinical studies and clinical trials the resulting benefits include improved human performance, such as increased endurance and faster recovery from injury,”

    MOLECULE: NAD+
    MOLECULAR TARGET: AMPK
    CELLULAR PROCESS: ENERGY METABOLISM
    HEADLINE DATA: 1230.5% AMPK ACTIVITY
    STUDY:Kawakami S, Fukuzawa Y, Ichikawa H, Sato T, Ide T, Maeda Y, Yamamoto T. NMN “Nicotinamide Mononucleotide” Activates Intracellular Energy and Approaches the Prevention and Improvement of Aging. J Biomed Res Environ Sci. 2022 May 21; 3(5): 560-565. doi: 10.37871/jbres1480, Article ID: JBRES1480,

The leading edge of human augmentation technology lies within cutting-edge institutional research programs.

Future Pharma's scientific advisory board extracts breakthroughs from world-renowned laboratories, including Harvard Medical School, Oxford University, NASA, WADA, and the U.S. military’s DARPA (Defense Advanced Research Projects Agency), translating next-gen discoveries into real-world products.

011
  • THE ULTIMATE ANABOLIC. SAFE, LEGAL AND OUTPERFORMS TRADITIONAL ANABOLICS.

    Research from German Sport University Cologne with WADA confirms natural 20E as exhibiting potent anabolic effect.

    MOLECULE:
    (+)-20-Hydroxyecdysone: A natural steroid-like molecule that mimics the effects of testosterone by targeting the mTOR molecular pathway.

    image 20e

    TARGETS

    MOLECULAR TARGET: mTOR. X3 - X5 fold greater activation.

    CELLULAR PROCESS: x200% greater protein synthesis in type1 and 2 fibres.

    image fibres

    Effects of Ecdysterone vs Control on soleus muscle fibre size. B- Effects of Ecdysterone (E) vs Control (K) on the size of different muscle fibre types (I, II, IIa, IIb) of the soleus. (Parr et al., 2014)

    STUDY:
    Researchers divided 46 young men into four groups. Three groups trained with weights during the 10-week trial. One group took a placebo [PL], while the other two groups used a supplement containing ecdysterone

    A group of men who exercised the recommended dose of 2 capsules of Peak Ecdysone per day [Ec1], which amounts to 12 milligrams of ecdysterone per day. The men who did not train also took this dose. Another group of physically active men took 8 capsules of Peak Ecdysone [Ec2] daily. That amounts to 48 milligrams ecdysterone per day.

    RESULTS:
    German biochemists associated with WADA (World Anti-Doping Agency) recorded 2kg of muscle growth and a 19.4% strength gain. They observed that (+)-20-Hydroxyecdysone has an anabolic effect comparable to DHT, the potent androgenic metabolite of testosterone, while exhibiting zero androgenic side effects and remaining 100% legal.

    image delta muscle

    image 1rm

    RESEARCH:
    Department for Molecular and Cellular Sports Medicine, German Sport University Cologne.

    Isenmann, Eduard et al. “Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans.”

    Gorelick-Feldman J, Cohick W, Raskin IEcdysteroids elicit a rapid Ca2+ flux leading to Akt activation and increased protein synthesis in skeletal muscle cellsSteroids.(2010 Oct)

    Gorelick-Feldman J, Maclean D, Ilic N, Poulev A, Lila MA, Cheng D, Raskin IPhytoecdysteroids increase protein synthesis in skeletal muscle cellsJ Agric Food Chem.(2008 May 28)

  • Recent studies on Urolithin A have revealed promising results for muscle performance, particularly in older adults. In human clinical trials, Urolithin A supplementation, specifically with the proprietary form Mitopure, demonstrated significant benefits:

    1. Muscle Strength: After four months of supplementation, participants experienced a 12% increase in muscle strength.

    2. Muscle Endurance: The study also showed an improvement in muscle endurance by 17%, achieved in just eight weeks.

    These effects are primarily attributed to Urolithin A's ability to trigger mitochondrial mitophagy, a process that enhances mitochondrial health by clearing out damaged mitochondria and promoting the creation of new ones. This cellular recycling process plays a critical role in improving overall muscle function, energy production, and endurance.

    By improving mitochondrial function, Urolithin A enables the body to perform better during physical activity, even without changes in exercise routines, and offers a pathway to mitigating age-related muscle decline.

    Singh A, D'Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, Aebischer P, Auwerx J, Rinsch C. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. 2022 May 17;3(5):100633. doi: 10.1016/j.xcrm.2022.100633. PMID: 35584623; PMCID: PMC9133463.

    Liu S, D'Amico D, Shankland E, Bhayana S, Garcia JM, Aebischer P, Rinsch C, Singh A, Marcinek DJ. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2144279. doi: 10.1001/jamanetworkopen.2021.44279. PMID: 35050355; PMCID: PMC8777576.

  • Recent research highlights Ursolic Acid's potent anabolic effects. Human trials have shown that supplementation with Ursolic Acid leads to significant muscle hypertrophy, with up to 30% muscle mass increase and reduced fat mass. These results are achieved through Ursolic Acid’s ability to upregulate IGF-1 (Insulin-like Growth Factor-1), a key signaling molecule for muscle growth and regeneration, while also enhancing other factors like irisin and reducing markers of atrophy.

    Further studies conducted by teams at Inje University in Korea and University of Iowa confirm these findings, demonstrating Ursolic Acid's dual role in improving body composition by building muscle while reducing fat mass—making it a promising agent for body recomposition efforts​(

    MDPI

    )​(

    KoreaMed

    ).



    Bang HS, Seo DY, Chung YM, Oh KM, Park JJ, Arturo F, Jeong SH, Kim N, Han J. Ursolic Acid-induced elevation of serum irisin augments muscle strength during resistance training in men. Korean J Physiol Pharmacol. 2014 Oct;18(5):441-6. doi: 10.4196/kjpp.2014.18.5.441. Epub 2014 Oct 17. Erratum in: Korean J Physiol Pharmacol. 2014 Dec;18(6):531. doi: 10.4196/kjpp.2014.18.6.531. PMID: 25352765; PMCID: PMC421112

    Ebert SM, Dyle MC, Bullard SA, Dierdorff JM, Murry DJ, Fox DK, Bongers KS, Lira VA, Meyerholz DK, Talley JJ, Adams CM. Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy. J Biol Chem. 2015 Oct 16;290(42):25497-511. doi: 10.1074/jbc.M115.681445. Epub 2015 Sep 3. PMID: 26338703; PMCID: PMC4646196.

  • Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, Shankhwar SN, Ahmad S. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril. 2010 Aug;94(3):989-96. doi: 10.1016/j.fertnstert.2009.04.046. Epub 2009 Jun 6. PMID: 19501822.

  • Huang WC, Hsu YJ, Li H, Kan NW, Chen YM, Lin JS, Hsu TK, Tsai TY, Chiu YS, Huang CC. Effect of Lactobacillus Plantarum TWK10 on Improving Endurance Performance in Humans. Chin J Physiol. 2018 Jun;61(3):163-170. doi: 10.4077/CJP.2018.BAH587. PMID: 2996217

  • Mero AA, Ojala T, Hulmi JJ, Puurtinen R, Karila TA, Seppälä T. Effects of alfa-hydroxy-isocaproic acid on body composition, DOMS and performance in athletes. J Int Soc Sports Nutr. 2010 Jan 5;7:1. doi: 10.1186/1550-2783-7-1. PMID: 20051111; PMCID: PMC2818616.


    Wilkinson DJ, et al. Effects of Leucine and its metabolite, β-hydroxy-β-methylbutyrate (HMB) on human skeletal muscle protein metabolism.


  • Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021 Jul 8;18(1):54. doi: 10.1186/s12970-021-00442-4. PMID: 34238308; PMCID: PMC8265078.

  • MOLECULE: GW501516 (Cardarine)

    Molecular Target: Peroxisome proliferator-activated receptor delta (PPARδ)

    Cellular Process: Activation of PPARδ enhances fatty acid oxidation, increases glucose uptake in skeletal muscle, and promotes the formation of type I muscle fibers. This leads to improved endurance, reduced fat storage, and a muscle fiber composition favorable for stamina.

    Headline Results: GW501516 has been shown to increase endurance performance by up to 68%, reduce fat mass by approximately 10%, and promote muscle fiber transformation, effectively mimicking the effects of exercise.

    Research:

    Developed by GlaxoSmithKline (GSK) for metabolic and cardiovascular diseases, GW501516 gained attention for its ability to activate PPARδ. In animal studies, mice treated with GW501516 experienced a 68% increase in endurance, running significantly longer than control groups 1. Additionally, treated subjects showed a 10% reduction in fat mass due to enhanced fatty acid metabolism 2. The compound also influenced muscle composition by increasing the proportion of oxidative (type I) muscle fibers, which are more efficient for endurance activities 333. However, long-term studies raised safety concerns after rodents developed cancers in several organs at high dosages 4. Consequently, GSK discontinued its development, and GW501516 was added to the World Anti-Doping Agency's prohibited list. While the compound demonstrates remarkable potential in metabolic enhancement, its adverse effects have limited its clinical application.

    References:

    1. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., ... & Evans, R. M. (2008). AMPK and PPARδ agonists are exercise mimetics. Cell, 134(3), 405-415.

    2. Oliver Jr, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., ... & Willson, T. M. (2001). A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proceedings of the National Academy of Sciences, 98(9), 5306-5311.

    3. Wang, Y. X., Zhang, C. L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., ... & Evans, R. M. (2004). Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biology, 2(10), e294.

    4. WADA. (2013). WADA warns against the use of GW501516. Retrieved from https://www.wada-ama.org/en/media/news/2013-03/wada-warns-against-the-use-of-gw501516

    Fan W, Waizenegger W, Lin CS, Sorrentino V, He MX, Wall CE, Li H, Liddle C, Yu RT, Atkins AR, Auwerx J, Downes M, Evans RM. PPARδ Promotes Running Endurance by Preserving Glucose. Cell Metab. 2017 May 2;25(5):1186-1193.e4. doi: 10.1016/j.cmet.2017.04.006. PMID: 28467934; PMCID: PMC5492977.

  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006 Aug 25;126(4):663-76. doi: 10.1016/j.cell.2006.07.024. Epub 2006 Aug 10. PMID: 16904174.

  • Martínez-Mármol R, Chai Y, Conroy JN, Khan Z, Hong SM, Kim SB, Gormal RS, Lee DH, Lee JK, Coulson EJ, Lee MK, Kim SY, Meunier FA. Hericerin derivatives activates a pan-neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory. J Neurochem. 2023 Jun;165(6):791-808. doi: 10.1111/jnc.15767. Epub 2023 Jan 31. PMID: 36660878; PMCID: PMC10952766.

  • Arthur ST, Zwetsloot KA, Lawrence MM, Nieman DC, Lila MA, Grace MH, Howden R, Cooley ID, Tkach JF, Keith MD, Demick JL, Blanton SE, Greiner RS, Bradley AM, Davenport ME, Badmaev V, Shanely RA. Ajuga turkestanica increases Notch and Wnt signaling in aged skeletal muscle. Eur Rev Med Pharmacol Sci. 2014;18(17):2584-92. PMID: 25268108.

  • Kijima I, Phung S, Hur G, Kwok SL, Chen S. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res. 2006 Jun 1;66(11):5960-7. doi: 10.1158/0008-5472.CAN-06-0053. PMID: 16740737.

  • Rascón B, Hubbard BP, Sinclair DA, Amdam GV. The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging (Albany NY). 2012 Jul;4(7):499-508. doi: 10.18632/aging.100474. PMID: 22868943; PMCID: PMC3433935.

  • Li W, Pandey AK, Yin X, Chen JJ, Stocco DM, Grammas P, Wang X. Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells. J Nutr Biochem. 2011 Mar;22(3):212-8. doi: 10.1016/j.jnutbio.2010.01.004. PMID: 20537519; PMCID: PMC2939222.

  • Yeh TS, Chuang HL, Huang WC, Chen YM, Huang CC, Hsu MC. Astragalus membranaceus improves exercise performance and ameliorates exercise-induced fatigue in trained mice. Molecules. 2014 Mar 3;19(3):2793-807. doi: 10.3390/molecules19032793. PMID: 24595275; PMCID: PMC6271379.

  • Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, Sarandi E, Thanasoula M, Spandidos DA, Tsatsakis A, Razgonova MP, Calina D. Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Mol Med Rep. 2019 Oct;20(4):3701-3708. doi: 10.3892/mmr.2019.10614. Epub 2019 Aug 23. PMID: 31485647; PMCID: PMC6755196.

AT FUTURE PHARMACEUTICALS WE’VE DEVELOPED A NEW GENERATION HUMAN AUGMENTATION BIOMOLECULES VALIDATED IN HUMAN CLINICAL TRIALS.

HUMAN CLINICAL TRIAL PIPELINE ////////////

PRE CLINICAL RESEARCH ////////////

Our current product pipeline includes preclinical and clinical trials for musculoskeletal , metabolism, aging, aerobic endurance, and neuronal cognition.

As you can see from the studies outlined below, there’s a lot happening behind the scenes at Future—
and a lot to look forward to.

WELCOME TO THE FUTURE

////////////

WELCOME TO THE FUTURE ////////////